|
Name |
Pestaloficiol F
|
Molecular Formula | C16H22O4 | |
IUPAC Name* |
(1aS,2S,7bS)-2-hydroxy-6,6-dimethyl-7b-(3-methylbut-2-enyl)-1a,2,3,5-tetrahydrooxireno[2,3-h]chromen-4-one
|
|
SMILES |
CC(=CC[C@@]12[C@@H](O1)[C@H](CC3=C2OC(CC3=O)(C)C)O)C
|
|
InChI |
InChI=1S/C16H22O4/c1-9(2)5-6-16-13-10(7-11(17)14(16)20-16)12(18)8-15(3,4)19-13/h5,11,14,17H,6-8H2,1-4H3/t11-,14-,16+/m0/s1
|
|
InChIKey |
DWRYREFBMYRRST-HZUKXOBISA-N
|
|
Synonyms |
Pestaloficiol F; CHEMBL1078031; (1aS,2S,7bS)-2-hydroxy-6,6-dimethyl-7b-(3-methylbut-2-enyl)-1a,2,3,5-tetrahydrooxireno[2,3-h]chromen-4-one
|
|
CAS | NA | |
PubChem CID | 44254170 | |
ChEMBL ID | CHEMBL1078031 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 278.34 | ALogp: | 1.3 |
HBD: | 1 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 59.1 | Aromatic Rings: | 3 |
Heavy Atoms: | 20 | QED Weighted: | 0.623 |
Caco-2 Permeability: | -4.582 | MDCK Permeability: | 0.00002510 |
Pgp-inhibitor: | 0.123 | Pgp-substrate: | 0.013 |
Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.058 |
30% Bioavailability (F30%): | 0.347 |
Blood-Brain-Barrier Penetration (BBB): | 0.773 | Plasma Protein Binding (PPB): | 81.12% |
Volume Distribution (VD): | 1.388 | Fu: | 20.27% |
CYP1A2-inhibitor: | 0.033 | CYP1A2-substrate: | 0.292 |
CYP2C19-inhibitor: | 0.176 | CYP2C19-substrate: | 0.769 |
CYP2C9-inhibitor: | 0.049 | CYP2C9-substrate: | 0.056 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.093 |
CYP3A4-inhibitor: | 0.077 | CYP3A4-substrate: | 0.366 |
Clearance (CL): | 15.998 | Half-life (T1/2): | 0.15 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.565 |
Drug-inuced Liver Injury (DILI): | 0.234 | AMES Toxicity: | 0.091 |
Rat Oral Acute Toxicity: | 0.959 | Maximum Recommended Daily Dose: | 0.078 |
Skin Sensitization: | 0.541 | Carcinogencity: | 0.929 |
Eye Corrosion: | 0.009 | Eye Irritation: | 0.099 |
Respiratory Toxicity: | 0.964 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003273 | 0.486 | D0W6DG | 0.258 | ||||
ENC002614 | 0.486 | D02JNM | 0.214 | ||||
ENC002617 | 0.392 | D0Y2YP | 0.211 | ||||
ENC003629 | 0.386 | D04SFH | 0.208 | ||||
ENC002618 | 0.382 | D09WYX | 0.203 | ||||
ENC002505 | 0.366 | D0W2EK | 0.203 | ||||
ENC004323 | 0.348 | D0H1QY | 0.203 | ||||
ENC005804 | 0.333 | D06IIB | 0.200 | ||||
ENC003122 | 0.319 | D03VFL | 0.200 | ||||
ENC004147 | 0.316 | D0Q6NZ | 0.200 |